Bucin Indicated

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Article 1, by : Sanjay Kalra, Hong Quang Thai , Chaicharn Deerochanawong , Goh Su-Yen ,

Dato’ Dr Mafauzy Mohamed , Tint Swe Latt , Than Than Aye , Zafar Ahmed Latif , Prasad
Katulanda , Touch Khun , Sum Satha, Vadsana Vongvandy

Title : Choice of Insulin in Type 2 Diabetes: A Southeast Asian Perspective

Selected sentence : It seems natural, therefore, for Southeast Asian nations to continue their
proactive and patient-centered approach toward the management of diabetes. This is
accomplished by ensuring publication and adoption of updated national clinical pathways and
guidelines, which reflect and respond to the lifestyle, dietary patterns, and biomedical as well as
psychosocial needs of their citizens.

Paraphrased Version : Therefore, as Southeast Asian countries continue a more active and
focused approach to diabetic patients. This goal can be achieved by ensuring the publication and
clinical adoption of an updated national clinical pathway along with guidelines to reflect the
lifestyle, dietary patterns, and biomedical and psychosocial needs of the Southeast Asian
community.

Article 2, by : Rayaz A. Malik . Emre Aldinc . Siew-Pheng Chan . Chaicharn Deerochanawong .


Chii-Min Hwu . Raymond L. Rosales . Chun-Yip Yeung . Koichi Fujii . Bruce Parsons

Title : Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from
Patient and Physician Surveys

Selected sentence : Most patients were monitored upon diagnosis of pDPN (range 55–97%), but
patients reported a shorter duration of monitoring compared with physicians. Both physicians
and patients agreed that it was patients who initiated conversations on pDPN. Physicians most
commonly referred to guidelines from the American Diabetes Association or local guidelines for
the management of pDPN. This study highlights important differences between physician and
patient perceptions of pDPN, which may impact on its diagnosis and treatment.

Paraphrased Version : Most of the patients were monitored after diagnosis of pDPN (range 55-
97%), but patients needed shorter checking times compared to doctors. Doctors most often use
guidelines from the American Diabetes Association. This study looks at the differences between
doctors 'and patients' perceptions about pDPN, which can have an impact on the diagnosis and
treatment of patients.

Article 3, by : Marilia B. Gomes a, * , Wolfgang Rathmann b , Bernard Charbonnel c , Kamlesh


Khunti d , Mikhail Kosiborod e,f , Antonio Nicolucci g , Stuart J. Pocock h , Marina V.
Shestakova i , Iichiro Shimomura j , Fengming Tang e , Hirotaka Watada k , Hungta Chen l ,
Javier Cid-Ruzafa m, Peter Fenici n , Niklas Hammar o , Filip Surmont p , Linong Ji q , on
behalf of the DISCOVER investigators

Title : Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the
global DISCOVER study

Selected sentence : Sustained glycaemic control, along with the management of comorbidities
such as hypertension and hyperlipidaemia, remains a key component of the effective treatment of
patients with type 2 diabetes mellitus. Clinical guidelines recommend the use of metformin, in
conjunction with lifestyle changes, as the first-line glucose-lowering therapy. However, when
metformin monotherapy fails to control glycated haemoglobin (HbA1c) levels, there is no
consensus on optimal subsequent treatments, and guidelines recommend an individualized and
patient-centred approach to drug selection based on patient characteristics including age,
duration of diabetes, presence of comorbidities and risk of adverse events including
hypoglycaemia and weight gain

Paraphrased Version : Continuous glycemic control, together with comorbid management such
as hypertension and hyperlipidemia, is an effective treatment for patients with type 2 diabetes
mellitus. The use of metformin, and lifestyle changes, is the first step in glucose-lowering
therapy. However, when metformin monotherapy fails to stabilize hemoglobin (HbA1c) levels, it
is recommended to take an individual and patient-centered approach to drug selection for
patients including age, diabetes time, presence of comorbidities and risk of side effects including
hypoglycemia and weight gain.

You might also like